FIELD: medicine, pharmaceutics.
SUBSTANCE: invention relates to compounds, which can be used as inhibitors of protease of hepatitis C virus, to pharmaceutical compositions, which contain said compounds, and to methods of their application for treatment of diseases mediated by protease of hepatitis C virus.
EFFECT: obtaining compounds, which can be used as inhibitors of protease of hepatitis C virus.
37 cl, 22 dwg, 7 tbl, 34 ex
| Title | Year | Author | Number |
|---|---|---|---|
| INHIBITORS OF PROTEASE OF HEPATITIS C VIRUS AND THEIR APPLICATION | 2008 |
|
RU2523790C2 |
| METHOD OF DETERMINING INHIBITOR, COVALENTLY BINDING TARGET POLYPEPTIDE | 2009 |
|
RU2542963C2 |
| METHOD OF SYNTHESISING E1-ACTIVATING ENZYME INHIBITORS | 2008 |
|
RU2553476C2 |
| ARYL, HETEROARYL AND HETEROCYCLIC COMPOUNDS FOR TREATMENT OF COMPLEMENT-MEDIATED DISORDERS | 2015 |
|
RU2707749C2 |
| COMPOUNDS FOR TREATING COMPLEMENT-MEDIATED DISORDERS | 2015 |
|
RU2703995C2 |
| PHOSPHORUS(N)AMIDATEACETAL AND PHOSPH(OH)ATACETAL COMPOUNDS | 2019 |
|
RU2796403C2 |
| HETEROARYL COMPOUNDS AND USING THEM | 2009 |
|
RU2536584C2 |
| PI3-KINASE INHIBITORS AND USE THEREOF | 2010 |
|
RU2595718C2 |
| SHIP1 MODULATORS AND METHODS RELATED THERETO | 2014 |
|
RU2679805C2 |
| CONDENSED QUINOLINE DERIVATIVE AND USE THEREOF | 2005 |
|
RU2384571C2 |
